Evidence map›Paper›PMID 36333398›Full record

ArticleScientific reports2022

Fabrication of an Au-doped Cu/Fe oxide-polymer core-shell nanoreactor with chemodynamic and photodynamic dual effects as potential cancer therapeutic agents.

Chun-Kai Sun, Yin-Hsu Wang, Yu-Liang Chen, Ting-Yu Lu, Hsi-Ying Chen, Shih-Chin Pan, Po-Chun Chen, Mei-Yi Liao, Jiashing Yu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Chun-Kai SunDepartment of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
Yin-Hsu WangDepartment of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
Yu-Liang ChenDepartment of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
Ting-Yu LuMaterials Science and Engineering Program, University of California San Diego, La Jolla, CA, 92093, USA.
Hsi-Ying ChenDepartment of Applied Chemistry, National Pingtung University, Pingtung, 90003, Taiwan.
Shih-Chin PanDepartment of Materials and Mineral Resources Engineering, Institute of Materials Science and Engineering, National Taipei University of Technology, Taipei, 10608, Taiwan.
Po-Chun ChenDepartment of Materials and Mineral Resources Engineering, Institute of Materials Science and Engineering, National Taipei University of Technology, Taipei, 10608, Taiwan.
Mei-Yi LiaoDepartment of Applied Chemistry, National Pingtung University, Pingtung, 90003, Taiwan. myliao@mail.nptu.edu.tw.
Jiashing YuDepartment of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan. jiayu@ntu.edu.tw.
National Taiwan University · TWNational Pingtung University · TWNational Taipei University of Technology · TWUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles are widely used in biomedical applications and cancer treatments due to their minute scale, multi-function, and long retention time. Among the various nanoparticles, the unique optical property derived from the localized surface plasmon resonance effect of metallic nanoparticles is a primary reason that metallic nanoparticles are researched and applied. Copper and Iron nanoparticles have the potential to generate hydroxyl radicals in excess H

Indexed as

Metal NanoparticlesNanoparticlesNeoplasmsCell Line, TumorFerric CompoundsGoldHumansHydrogen PeroxideNanotechnologyOxidesPolymersSinglet OxygenTumor MicroenvironmentFerric CompoundsferriteGoldHydrogen PeroxideOxidesPolymersSinglet Oxygen

Identifiers

PMID36333398
PMCPMC9636373
OpenAlexW4308192221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.